DIA 2020 Virtual Global Annual Meeting has ended

Create Your Own Event

DIA 2020 Virtual Global Annual Meeting

12:30pm EDT

#0001 L: Student and Emerging Professionals Forum TBD

1:30pm EDT

#0002 L: Student and Young Professionals Resume Workshop TBD

4:00pm EDT

#0004 SL: Student Self-Awareness Workshop TBD

8:00am EDT

#100 SL: DIA Global Annual Meeting – Opening DIAmond and Plenary Session TBD

11:00am EDT

#106 SL: Clinical Trials in a Digital Age: A Modern Approach to an Outdated Model TBD #109 L: International Convergence on Regulatory Review and HTA: Getting the “Universal Evidence” We Need for Decisions on Innovation TBD

12:30pm EDT

#112 L-RT: Round Table Discussion: Patients First! How FDA is Making Patients a Priority TBD

1:30pm EDT

#119 L: How Do You Oversee and Manage New Centralized/Remote/Site Monitoring Models? What Should you Measure to Gain Insights? TBD #121 SL: Non-Profit Organizations Role in Accelerating Preclinical Compound Testing to Fuel the Rare Disease Clinical Pipeline TBD #124 SL: Gene Therapy Manufacturing: How Can Innovation Help Overcome This Anticipated Hurdle? TBD

3:30pm EDT

#129 SL: The Rare Disease Clinical Outcome Assessment Consortium: Aiming to Fulfill Unmet Drug Development Endpoint Measurement Needs TBD #131 L: Engaging Patients to Support the Modernization of ClinicalTrials.gov TBD #132 SL: Benchmarking and Identifying Opportunities to Improve Intentional Dose Non-Adherence in Clinical Trials TBD #134 L: Should a COVID-19 Vaccination be Legally Mandated and Can HTA Inform That Decision? TBD

8:00am EDT

#204 L: Implementing Quality by Design for Clinical Trials: New Tools, Case Studies, and Multi-Stakeholder Discussion TBD

9:30am EDT

#210 SL: Clinical Electronic Structured Harmonized Protocol (CeSHarP): ICH M11 - Status Update TBD #214 L: GCP Quality and Compliance: The Regulators’ Perspective TBD

10:45am EDT

#216 L-RT: Round Table Discussion: Patient-Centricity: How Do We Measure Progress in Involving Patients in Drug Development and Drug Safety? TBD

11:30am EDT

#221 L: Non-Traditional Clinical Trials Require a Non-Traditional Workforce TBD #223 L: Next Generation Analytics: Harnessing the Power of Nonclinical SEND Datasets to Improve Success in Early Clinical Development TBD #224 SL: Sponsor and Regulator Challenges, Risks, and Mitigation Strategies for Ensuring Third-Party Oversight of Vendors: Is Your Study Data at Risk? TBD

1:15pm EDT

#229 L-RT: Round Table Discussion: RIM Working Group Update TBD

2:00pm EDT

#233 L: Practical Considerations for Robust Evaluation of Risk Minimization Programs: Regulatory, Industry, and Service Provider Insights TBD #236 L: FDA Data Standards Update TBD #239 L: The FDA Complex Innovative Trial Design Pilot Program: Case Examples TBD

3:15pm EDT

#240 L-SB: On the Soapbox: At a Time of High Priced Medicines and a Global Pandemic - How Do We Make Medicines Accessible and Affordable to All? TBD #242 L-RT: Round Table Discussion: Examining Diversity in Clinical Trials TBD

4:00pm EDT

#247 SL: Engaging Caregivers in Research and Medical Product Development TBD

8:00am EDT

#301 SL: Combining Multiple Real World Data Sources to Maximize Value TBD #303 SL: Detection of Anomalies in eCOA Data and Metadata for More Pre-Emptive, Evidence-Based Risk Management TBD #304.1 L: ICH 30th Anniversary: Achievements and Future Prospects TBD

9:30am EDT

#310 L: Global Rare Disease Town Hall TBD

11:30am EDT

#318 L: Data Strategy and Privacy Compliance in the Age of Digital Health: GDPR, HIPAA, and CCPA Implications TBD #321 L: Recommendations for a Strategic Response to the COVID-19 Pandemic TBD

12:45pm EDT

#322 L-RT: Round Table Discussion: Data Strategy and Privacy Compliance in the Age of Digital Health: GDPR, HIPAA, and CCPA Implications TBD

2:00pm EDT

#332 SL: Optimizing Communication with Patients to Support Meaningful Feedback into the Research Process TBD

4:00pm EDT

#339 SL: The Development of Novel Digital Endpoints TBD

8:00am EDT

#402 L: FDA Perspectives on Modernization of Clinical Trials: Real World Evidence, Decentralized Clinical Trials, and Digital Health Technologies TBD #404 L: Incorporating Patient Input into Medical Product Development and the US Food and Drug Administration’s Decision-Making TBD

9:30am EDT

#411 L: Qualification and Oversight in Decentralized Trials: Practical Considerations for Clinical Operations and Quality Oversight TBD #412 L: Telling Health Stories for Drug Development TBD

11:30am EDT

#421 L: Quantitative Benefit-Risk Assessment: What Methods are Being Used? How Far has Industry Come? TBD #422 L: How the FDA’s MyStudies Platform is Accelerating the Use of Digital Technology in Clinical Research and Clinical Trials TBD

2:00pm EDT

#431 L: FDA Town Hall TBD

5:00pm EDT

#501 OD: ON DEMAND - Advancing Risk Management: What Can Evidence-Based Practices to Disseminate Healthcare Evidence into Practice Teach Us? TBD #503 OD: ON DEMAND - MedDRA® Labeling Groupings for Enhanced Communication of Safety Concepts: Cinderella’s Glass Slipper? TBD #505 OD: ON DEMAND - Older People Can’t Use ePRO and Other Industry Myths: An Interactive Debate TBD #507 OD: ON DEMAND - Managing Global Clinical Trials in Emerging Regions: Latin America TBD #509 OD: ON DEMAND - Faster, Better, Cheaper: The Changing Role of Real World Data in Drug Development TBD #516 OD: ON DEMAND - Deploying Machine Learning in Data Management TBD #517 OD: ON DEMAND - Getting Real About Data Sharing for Drug Development and Drug Safety: What COVID-19 is Teaching us About the Possibilities and How to Move From Anomaly to Precedent TBD #531 OD: ON DEMAND - Global Commission Harnessing Cutting-Edge Technology to Accelerate Diagnosis of Rare Diseases in Children TBD #532 OD: ON DEMAND - Setting a Strategic Foundation for Mutually Beneficial Collaborations Between Industry and Patient Organizations TBD #542 OD: ON DEMAND - Impact of Advanced Data Analytics Capabilities on Quality and Compliance Activities: Overview and Case Studies TBD #543 OD: ON DEMAND - Opportunities and Challenges for ICH E6 (GCP) Renovation TBD #547 OD: ON DEMAND - New Drugs Regulatory Program Modernization TBD #551 OD: ON DEMAND - Advancing Clinical Trial Innovation Through Model-Informed Drug Development TBD #553 OD: ON DEMAND - What Makes Real World Data Trustworthy: A Focus on Design and Data TBD #554 OD: ON DEMAND - Strengthening Food and Drug Regulatory Systems Abroad: Recommendations from the FDA-Commissioned NASEM Report TBD #555 OD: ON DEMAND - Updates of Drug Evaluation and Inspection in China TBD #549 OD: ON DEMAND - Translating Frequently Collected Patient Experience Data into Meaningful Trial Endpoints TBD #559 OD: ON DEMAND - Replication of Randomized Controlled Trials Using Real World Data: What Does Good Look Like? TBD #565 OD: ON DEMAND - Considerations for Long-Term Outcomes Data Collection for Value-Based Payment Arrangements TBD #566 OD: ON DEMAND - Subscription Models to Incentive Antimicrobial Innovation TBD #570 OD: ON DEMAND - Networking for Everyone: Extrovert/Introvert/Centrovert TBD